GovChime
Notice ID: 85b7ff1081c64b21a637de13d1712852Award NoticeAwarded

Sumatriptan Succinate Tablets

Awarded on July 25, 2023. Full description on SAM.gov.

Awarded tounder SPE2D223D0009 (source: SAM.gov award notice)• $14.9M

Description

Modification SPE2D223D0009 P00007 posted to announce exercising of Option Year Three (3), effective July 25, 2026 through July 24, 2027.

Full description on SAM.gov

Overview

Agency:
Department of WarDEFENSE LOGISTICS AGENCY
Office:TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Posted:July 1, 2026
NAICS:325412: Pharmaceutical Preparation Manufacturing
Last Updated:Oct 28, 2026
First published:
Last updated on SAM.gov:
PSC:6505: DRUGS AND BIOLOGICALS
Set-Aside:Not specified
Type:Award Notice
Place of Performance:Carole Park, Australian Capital Territory, 4300
Award Date:Jul 25, 2023
Award Amount (SAM.gov award notice):$14.9M

Award Overview

Award Number

SPE2D223D0009

Award Amount (SAM.gov award notice)

$14.9M

Award Date

Jul 25, 2023

Awardee

Awardee UEI

GQLDJJ8AQNN5

Awardee CAGE Code

1HT23

Awardee Address

Camarillo, CA 93012, UNITED STATES

Line Item Number

SPE2D223D0009

Original Solicitation

Notice ID: 85b7ff1081c64b21a637de13d1712852

Posted Date: Jul 1, 2026

Original Response Deadline: Not specified

Contract Details

SPE2D223D0009
Signed: Jul 27, 2026Defense Logistics Agency
View the award

Contacts

Contracting Officer

Primary Contact

Nancy Fernandez
nancy.fernandez@dla.mil
2157374955

Secondary Contact

Jason Wray
jason.wray@dla.mil
215-737-0614

Documents

Files (9)

  • SF30_SPE2D223D0009P00007.pdf

    116 KBAdded in Award Notice version 6Posted
    Download

  • SPE2D223D0009 P00005 SIGNED MOD.pdf

    18 KBAdded in Award Notice version 5Posted
    Download

  • SF30_SPE2D223R00030003.PDF

    18 KBAdded in Solicitation version 5Posted
    Download

  • Signed_SF30_SPE2D223D0009P00002_Option 1_Sumatriptan.pdf

    113 KBAdded in Award Notice version 4Posted
    Download

  • SF30_SPE2D223R00030002.PDF

    18 KBAdded in Solicitation version 4Posted
    Download

  • Signed SPE2D223D0009 P00001.pdf

    1.5 MBAdded in Award Notice version 3Posted
    Download

  • SF30_SPE2D223R00030001.PDF

    18 KBAdded in Solicitation version 3Posted
    Download

  • Signed Award SPE2D2-23-D-0009 Sumatriptan Succinate Tablets.pdf

    840 KBAdded in Award Notice version 2Posted
    Download

  • Sumatriptan Succinate Tablets National Contract Solicitation SPE2D223R0003.pdf

    1.3 MBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 1
    Version 1Solicitation

    Sumatriptan Succinate Tablets

    Notice a437801f8f3b4b40af49b9301fd6bc3f on SAM.gov

  2. 2
    Version 2Award Notice

    Type changed from Solicitation to Award Notice

    Sumatriptan Succinate Tablets

    Notice 763013368ba34992940ec9939fcd5ca7 on SAM.gov

  3. 3
    Version 3Award Notice

    Sumatriptan Succinate Tablets

    Notice cb46cfe7772d42e28141b402adcb8c5f on SAM.gov

  4. 4
    Version 4Award Notice

    Sumatriptan Succinate Tablets

    Notice 8fa347e7f19642489f5597bf076d02a2 on SAM.gov

  5. 5
    Version 5Award Notice

    Sumatriptan Succinate Tablets

    Notice 03e563923eba4961b27d01f9383f7fd8 on SAM.gov

  6. 6
    Version 6Award NoticeCurrent

    Sumatriptan Succinate Tablets

    Notice 85b7ff1081c64b21a637de13d1712852 on SAM.gov

Similar Opportunities

Title
Phase
Agency
NAICS
Set Aside
Posted
Deadline
Location

Additional Details

Solicitation Number

SPE2D223R0003

Archive Date

Jul 27, 2030

Place of Performance Country

AUSTRALIA

Office Address

PHILADELPHIA, PA, 19111

Related on GovChime